{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:09:59Z","timestamp":1777432199313,"version":"3.51.4"},"reference-count":131,"publisher":"Bentham Science Publishers Ltd.","issue":"28","funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR20803\/TRM\/120\/118\/2016"],"award-info":[{"award-number":["BT\/PR20803\/TRM\/120\/118\/2016"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2019,12,19]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The considerable increase in the incidence of Candida infection in recent times has prompted the use of numerous antifungal agents, which has resulted in the development of resistance towards various antifungal agents. With rising Candida infections, the need for design and development of novel antifungal agents is in great demand. However, new therapeutic approaches are very essential in preventing the mortality rate and improving the patient outcome in those suffering from Candida infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The present review objective is to describe the burden, types of Candidiasis, mechanism of action of antifungal agents and its resistance and the current novel approaches used to combat candidiasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We have collected and analyzed 135 different peer-reviewed literature studies pertinent to candidiasis. In this review, we have compiled the major findings from these studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and Conclusion:<\/jats:title><jats:p>The review describes the concerns related to candidiasis, its current treatment strategy, resistance mechanisms and imminent ways to tackle the problem. The review explored that natural plant extracts and essential oils could act as sources of newer therapeutic agents, however, the focus was on novel strategies, such as combinational therapy, new antibodies, utilization of photodynamic therapy and adaptive transfer primed immune cells with emphasis on the development of effective vaccination.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026619666191029145209","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T10:33:10Z","timestamp":1572431590000},"page":"2610-2628","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Paradigm Shift in the Development of Anti-Candida Drugs"],"prefix":"10.2174","volume":"19","author":[{"given":"D.V.","family":"Gowda","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru- 570015, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Afrasim","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Hail University, Hail, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.I.","family":"Meenakshi","sequence":"additional","affiliation":[{"name":"Department of Prosthodontics and Crown & Bridge, JSS Dental College and Hospital, JSS Academy of Higher Education and Research, Mysuru-570015, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Manohar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru- 570015, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hemalatha","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, JSS Medical College & Hospital, JSS Academy of Higher Education and Research, Mysuru - 570004, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Siddaramaiah","sequence":"additional","affiliation":[{"name":"Department of Polymer Science and Technology, Sri Jayachamarajendra College of Engineering, JSS Science and Technology University, Mysuru - 570006, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sathishbabu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru- 570015, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M. Danish","family":"Rizvi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Hail University, Hail, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Hail, Hail, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Kamal","sequence":"additional","affiliation":[{"name":"King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3389\/fmicb.2015.01391","volume":"6","author":"Patil S.","year":"2015","unstructured":"Patil S.; Rao R.S.; Majumdar B.; Anil S.; Clinical appearance of oral candida infection and therapeutic strategies. Front Microbiol 2015,6,1391","journal-title":"Front Microbiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/378745","volume":"37","author":"Gudlaugsson O.","year":"2003","unstructured":"Gudlaugsson O.; Gillespie S.; Lee K.; Vande Berg J.; Hu J.; Messer S.; Herwaldt L.; Pfaller M.; Diekema D.; Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003,37(9),1172-1177","journal-title":"Clin Infect Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tripleo.2003.04.002","volume":"98","author":"Ramage G.","year":"2004","unstructured":"Ramage G.; Tomsett K.; Wickes B.L.; L\u00f3pez-Ribot J.L.; Redding S.W.; Antionio S.; Denture stomatitis: a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004,98(1),53-59","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref=4","first-page":"110","volume":"6","author":"Razak P.","year":"2014","unstructured":"Razak P.; Richard K.; Rekha T.; Hafiz K.; Kumar K.; Sameer K.; Geriatric oral health a review article. J Int Oral Health 2014,6,110-116","journal-title":"J Int Oral Health"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/BF02814436","volume":"46","author":"Dorko E.","year":"2001","unstructured":"Dorko E.; Jen\u010da A.; Pilip\u010dinec E.; Danko J.; Svick\u00fd E.; Tk\u00e1cikov\u00e1 L.; Candida-associated denture stomatitis. Folia Microbiol (Praha) 2001,46(5),443-446","journal-title":"Folia Microbiol (Praha)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1399-302X.1990.tb00232.x","volume":"5","author":"Cumming C.G.","year":"1990","unstructured":"Cumming C.G.; Wight C.; Blackwell C.L.; Wray D.; Denture stomatitis in the elderly. Oral Microbiol Immunol 1990,5(2),82-85","journal-title":"Oral Microbiol Immunol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/PMC.S14459","volume":"6","author":"Fair R.J.","year":"2014","unstructured":"Fair R.J.; Tor Y.; Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem 2014,6,25-64","journal-title":"Perspect Medicin Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1155\/2012\/713687","volume":"2012","author":"Vandeputte P.","year":"2012","unstructured":"Vandeputte P.; Ferrari S.; Coste A.T.; Antifungal resistance and new strategies to control fungal infections. Int J Microbiol 2012,2012,26","journal-title":"Int J Microbiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1532-849X.2011.00698.x","volume":"20","author":"Gendreau L.","year":"2011","unstructured":"Gendreau L.; Loewy Z.G.; Epidemiology and etiology of denture stomatitis. J Prosthodont 2011,20(4),251-260","journal-title":"J Prosthodont"},{"key":"ref=10","first-page":"1","volume":"8","year":"2017","unstructured":"A.C.A.; de Oliveira, H.C.; Fusco-Almeida, A.M.; de Melo, W.C.M.A.; Costa-Orlandi, C.B.; Marcos, C.M.; Mendes-Giannini, M.J.S.; Scorzoni, L.; Assato, P.A. Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol de Paula e Silva2017,8,1-23","journal-title":"Front Microbiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1590\/rou.2014.018","volume":"43","author":"De R.","year":"2014","unstructured":"De R.; Antifungal activity of components used for decontamination of dental prostheses on the growth of Candida albicans. Rev Odontol UNESP 2014,43,137-143","journal-title":"Rev Odontol UNESP"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/IDR.S124918","volume":"10","author":"Wiederhold N.P.","year":"2017","unstructured":"Wiederhold N.P.; Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist 2017,10,249-259","journal-title":"Infect Drug Resist"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.3389\/fmicb.2018.02997","volume":"9","author":"Thomaz D.Y.","year":"2018","unstructured":"Thomaz D.Y.; de Almeida J.N.; Lima G.M.E.; Nunes M.O.; Camargo C.H.; Grenfell R.C.; Benard G.; Del Negro G.M.B.; An azole-resistant candida parapsilosis outbreak: clonal persistence in the intensive care unit of a brazilian teaching hospital. Front Microbiol 2018,9,2997","journal-title":"Front Microbiol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/1040841X.2014.974500","volume":"42","author":"Rodrigues M.E.","year":"2016","unstructured":"Rodrigues M.E.; Silva S.; Azeredo J.; Henriques M.; Novel strategies to fight Candida species infection. Crit Rev Microbiol 2016,42(4),594-606","journal-title":"Crit Rev Microbiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jof2040026","volume":"2","author":"Pianalto K.M.","year":"2016","unstructured":"Pianalto K.M.; Alspaugh J.A.; New horizons in antifungal therapy. J Fungi (Basel) 2016,2(4),10-12","journal-title":"J Fungi (Basel)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/1871526515666150320162036","volume":"15","author":"Hani U.","year":"2015","unstructured":"Hani U.; Shivakumar H.G.; Vaghela R.; Osmani R.A.M.; Shrivastava A.; Candidiasis: a fungal infection--current challenges and progress in prevention and treatment. Infect Disord Drug Targets 2015,15(1),42-52","journal-title":"Infect Disord Drug Targets"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.mycmed.2019.07.006","volume":"29","author":"Ghazi S.","year":"2019","unstructured":"Ghazi S.; Rafei R.; Osman M.; El Safadi D.; Mallat H.; Papon N.; Dabboussi F.; Bouchara J-P.; Hamze M.; The epidemiology of candida species in the middle east and north africa. J Mycol Med 2019,29(3),245-252","journal-title":"J Mycol Med"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057","volume":"3","author":"Bongomin F.","year":"2017","unstructured":"Bongomin F.; Gago S.; Oladele R.O.; Denning D.W.; Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel) 2017,3(4)","journal-title":"J Fungi (Basel)"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jof3030041","volume":"3","author":"Kaur H.","year":"2017","unstructured":"Kaur H.; Chakrabarti A.; Strategies to reduce mortality in adult and neonatal candidemia in developing countries. J Fungi (Basel) 2017,3(3),41","journal-title":"J Fungi (Basel)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"Wisplinghoff H.","year":"2004","unstructured":"Wisplinghoff H.; Bischoff T.; Tallent S.M.; Seifert H.; Wenzel R.P.; Edmond M.B.; Nosocomial bloodstream infections in US Hospitals: Analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004,39,309-317","journal-title":"Clin Infect Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"Pfaller M.A.","year":"2007","unstructured":"Pfaller M.A.; Diekema D.J.; Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007,20(1),133-163","journal-title":"Clin Microbiol Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","volume":"62","author":"Sardi J.C.","year":"2013","unstructured":"Sardi J.C.; Scorzoni L.; Bernardi T.; Fusco-Almeida A.M.; Mendes Giannini M.J.; Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013,62(Pt 1),10-24","journal-title":"J Med Microbiol"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019273","volume":"5","author":"K\u00f6hler J.R.","year":"2014","unstructured":"K\u00f6hler J.R.; Casadevall A.; Perfect J.; The spectrum of fungi that infects humans. Cold Spring Harb Perspect Med 2014,5(1)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=24","first-page":"22","volume":"62","author":"Seyedmousavi S.H.S.","year":"2018","unstructured":"Seyedmousavi S.H.S.; Ilkit M.; Estimated burden of serious human fungal diseases in turkey. Mycoses 2018,62(1),22-31","journal-title":"Mycoses"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005522","volume":"12","author":"Tati S.","year":"2016","unstructured":"Tati S.; Davidow P.; McCall A.; Hwang-Wong E.; Rojas I.G.; Cormack B.; Edgerton M.; Candida glabrata binding to candida albicans hyphae enables its development in oropharyngeal candidiasis. PLoS Pathog 2016,12(3)","journal-title":"PLoS Pathog"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/pmj.78.922.455","volume":"78","author":"Akpan A.","year":"2002","unstructured":"Akpan A.; Morgan R.; Oral candidiasis. Postgrad Med J 2002,78(922),455-459","journal-title":"Postgrad Med J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1741-2358.2009.00285.x","volume":"27","author":"Paranhos Hde.","year":"2010","unstructured":"Paranhos Hde.; F.; Lovato da Silva, C.H.; de Souza, R.F.; Pontes, K.M. Evaluation of three indices for biofilm accumulation on complete dentures. Gerodontology 2010,27(1),33-40","journal-title":"Gerodontology"},{"key":"ref=28","first-page":"4675","volume":"75","author":"Cassone A.","year":"2007","unstructured":"Cassone A.; De Bernardis F.; Santoni G.; Anticandidal immunity and vaginitis: novel opportunities for immune intervention. Am Soc Microbiol 2007,75,4675-4686","journal-title":"Am Soc Microbiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1128\/CMR.00076-09","volume":"23","author":"Achkar J.M.","year":"2010","unstructured":"Achkar J.M.; Fries B.C.; Candida infections of the genitourinary tract. Clin Microbiol Rev 2010,23(2),253-273","journal-title":"Clin Microbiol Rev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0146-0005(03)00066-1","volume":"27","author":"Rowen J.L.","year":"2003","unstructured":"Rowen J.L.; Thrush O.C.; Mucocutaneous candidiasis. Semin Perinatol 2003,27(5),406-413","journal-title":"Semin Perinatol"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/283239","volume":"2011","author":"Firinu D.","year":"2011","unstructured":"Firinu D.; Massidda O.; Lorrai M.M.; Serusi L.; Peralta M.; Barca M.P.; Serra P.; Manconi P.E.; Successful treatment of chronic mucocutaneous candidiasis caused by azole-resistant Candida albicans with posaconazole. Clin Dev Immunol 2011,2011","journal-title":"Clin Dev Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.15406\/joentr.2017.08.00249","volume":"8","author":"Acharya S.","year":"2017","unstructured":"Acharya S.; Lohe V.K.; Bhowate R.R.; Diagnosis and management of Pseudomembranous candidiasis. J Otolaryngol ENT Res 2017,8(3),249","journal-title":"J Otolaryngol ENT Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/iub.1973","volume":"71","author":"Kim S.","year":"2019","unstructured":"Kim S.; Woo E-R.; Lee D.G.; Synergistic antifungal activity of isoquercitrin: apoptosis and membrane permeabilization related to reactive oxygen species in Candida albicans. IUBMB Life 2019,71(2),283-292","journal-title":"IUBMB Life"},{"key":"ref=34","author":"Jeanmonod R.","year":"2019","unstructured":"Jeanmonod R.; Jeanmonod D.; Vaginal Candidiasis (Vulvovaginal Candidiasis) 2019","journal-title":"Vaginal Candidiasis (Vulvovaginal Candidiasis)"},{"key":"ref=35","first-page":"1","volume":"4","author":"Ben-Ami R.","year":"2018","unstructured":"Ben-Ami R.; Treatment of invasive candidiasis: a narrative review. J fungi (Basel, Switzerland) 2018,4,1-18","journal-title":"J fungi (Basel, Switzerland)"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.jinf.2016.04.023","volume":"72","author":"van de Veerdonk F.L.","year":"2016","unstructured":"van de Veerdonk F.L.; Netea M.G.; Treatment options for chronic mucocutaneous candidiasis. J Infect 2016,72(Suppl.),S56-S60","journal-title":"J Infect"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/2319-7250.160655","volume":"16","author":"Sinha S.","year":"2015","unstructured":"Sinha S.; Sarkar R.; Garg V.; Successful treatment of chronic mucocutaneous candidiasis with oral antifungals and levamisole. Indian J Paediatr Dermatol 2015,16,159","journal-title":"Indian J Paediatr Dermatol"},{"key":"ref=38","author":"Endy Ryan E.T.","year":"2020","unstructured":"Endy Ryan E.T.; Hill D.R.; Solomon T.; TP; Aronson, N Hunter\u2019s tropical medicine and emerging infectious diseases 2020","journal-title":"TP; Aronson, N Hunter\u2019s tropical medicine and emerging infectious diseases"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s001340050552","volume":"24","author":"Vincent J.L.","year":"1998","unstructured":"Vincent J.L.; Anaissie E.; Bruining H.; Demajo W.; el-Ebiary M.; Haber J.; Hiramatsu Y.; Nitenberg G.; Nystr\u00f6m P.O.; Pittet D.; Rogers T.; Sandven P.; Sganga G.; Schaller M.D.; Solomkin J.; Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998,24(3),206-216","journal-title":"Intensive Care Med"},{"key":"ref=40","author":"Pilmis B.","year":"2009","unstructured":"Pilmis B.; Fanny Z.Y.; Lortholary O.; Systemic Candidiasis 2009","journal-title":"Systemic Candidiasis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10096-018-3400-x","volume":"38","author":"Dekkerov\u00e1 J.","year":"2019","unstructured":"Dekkerov\u00e1 J.; Lopez-Ribot J.L.; Bujd\u00e1kov\u00e1 H.; Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen. Eur J Clin Microbiol Infect Dis 2019,38(1),101-108","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0163-4453(93)92761-K","volume":"26","author":"Graninger W.","year":"1993","unstructured":"Graninger W.; Presteril E.; Schneeweiss B.; Teleky B.; Georgopoulos A.; Treatment of Candida albicans fungaemia with fluconazole. J Infect 1993,26(2),133-146","journal-title":"J Infect"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/insects10010020","volume":"10","author":"Wade A.","year":"2019","unstructured":"Wade A.; Lin C.H.; Kurkul C.; Regan E.R.; Johnson R.M.; Combined toxicity of insecticides and fungicides applied to california almond orchards to honey bee larvae and adults. Insects 2019,10(1),1-11","journal-title":"Insects"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"i19","DOI":"10.1093\/jac\/dkm428","volume":"61","author":"Pasqualotto A.C.","year":"2008","unstructured":"Pasqualotto A.C.; Denning D.W.; New and emerging treatments for fungal infections. J Antimicrob Chemother 2008,61(Suppl. 1),i19-i30","journal-title":"J Antimicrob Chemother"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3389\/fmicb.2018.01351","volume":"9","author":"de Oliveira Santos G.C.","year":"2018","unstructured":"de Oliveira Santos G.C.; Vasconcelos C.C.; Lopes A.J.O.; de Sousa Cart\u00e1genes M.D.S.; Filho A.K.D.B.; do Nascimento F.R.F.; Ramos R.M.; Pires E.R.R.B.; de Andrade M.S.; Rocha F.M.G.; de Andrade Monteiro C.; Candida infections and therapeutic strategies: mechanisms of action for traditional and alternative agents. Front Microbiol 2018,9,1351","journal-title":"Front Microbiol"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1871526516666151209155447","volume":"16","author":"Saini S.C.D.","year":"2016","unstructured":"Saini S.C.D.; Echinocandin susceptibility profile of fluconazole resistant. Infect Disord Drug Targets 2016,16,63-68","journal-title":"Infect Disord Drug Targets"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ijantimicag.2019.05.016","volume":"54","author":"Rajasekharan S.K.","year":"2019","unstructured":"Rajasekharan S.K.; Lee J-H.; Lee J.; Aripiprazole repurposed as an inhibitor of biofilm formation and sterol biosynthesis in multidrug-resistant Candida albicans. Int J Antimicrob Agents 2019,54(4),518-523","journal-title":"Int J Antimicrob Agents"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1089\/jop.2018.0089","volume":"35","author":"Lakhani P.","year":"2019","unstructured":"Lakhani P.; Patil A.; Majumdar S.; Challenges in the polyene- and azole-based pharmacotherapy of ocular fungal infections. J Ocul Pharmacol Ther 2019,35(1),6-22","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mib.2018.02.005","volume":"45","author":"Revie N.M.","year":"2018","unstructured":"Revie N.M.; Iyer K.R.; Robbins N.; Cowen L.E.; Antifungal drug resistance: evolution, mechanisms and impact. Curr Opin Microbiol 2018,45,70-76","journal-title":"Curr Opin Microbiol"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/crj.12687","volume":"12","author":"Krishnasamy L.","year":"2018","unstructured":"Krishnasamy L.; Krishnakumar S.; Kumaramanickavel G.S.C.; Molecular mechanisms of antifungal drug resistance in candida species. J Clin Diagn Res 2018,12,1-6","journal-title":"J Clin Diagn Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1128\/AAC.40.12.2835","volume":"40","author":"Albertson G.D.","year":"1996","unstructured":"Albertson G.D.; Niimi M.; Cannon R.D.; Jenkinson H.F.; Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 1996,40(12),2835-2841","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1099\/00221287-143-2-405","volume":"143","author":"Sanglard D.","year":"1997","unstructured":"Sanglard D.; Ischer F.; Monod M.; Bille J.; Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 1997,143(Pt 2),405-416","journal-title":"Microbiology"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1099\/jmm.0.013227-0","volume":"59","author":"Kothavade R.J.","year":"2010","unstructured":"Kothavade R.J.; Kura M.M.; Valand A.G.; Panthaki M.H.; Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol 2010,59(Pt 8),873-880","journal-title":"J Med Microbiol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1128\/AAC.18.1.158","volume":"18","author":"Dick J.D.","year":"1980","unstructured":"Dick J.D.; Merz W.G.; Saral R.; Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother 1980,18(1),158-163","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1128\/AAC.01653-05","volume":"50","author":"Balashov S.V.","year":"2006","unstructured":"Balashov S.V.; Park S.; Perlin D.S.; Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1. Antimicrob Agents Chemother 2006,50(6),2058-2063","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1086\/324629","volume":"34","author":"Negredo E.","year":"2002","unstructured":"Negredo E.; Cruz L.; Paredes R.; Ruiz L.; Fumaz C.R.; Bonjoch A.; Gel S.; Tuldr\u00e0 A.; Balagu\u00e9 M.; Johnston S.; Arn\u00f3 A.; Jou A.; Tural C.; Sirera G.; Romeu J.; Clotet B.; Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression. Clin Infect Dis 2002,34(4),504-510","journal-title":"Clin Infect Dis"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"Allen T.M.","year":"2013","unstructured":"Allen T.M.; Cullis P.R.; Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013,65(1),36-48","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/jps.22513","volume":"100","author":"Julia C.","year":"2011","unstructured":"Julia C.; Schwarz, Hanspeter K \u00a8Ahlig, Nadejda B. Matsko, Martin Kratzel, Markus Husa, C.V. Decrease of liposomal size and retarding effect on fluconazole skin permeation by lysine derivatives. J Pharm Sci 2011,100,2911-2919","journal-title":"J Pharm Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1517\/17425240903071029","volume":"6","author":"Sinico C.","year":"2009","unstructured":"Sinico C.; Fadda A.M.; Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 2009,6(8),813-825","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.nano.2012.07.004","volume":"9","author":"Alam M.","year":"2013","unstructured":"Alam M.; Zubair S.; Farazuddin M.; Ahmad E.; Khan A.; Zia Q.; Malik A.; Mohammad O.; Development, characterization and efficacy of niosomal diallyl disulfide in treatment of disseminated murine candidiasis. Nanomedicine (Lond) 2013,9(2),247-256","journal-title":"Nanomedicine (Lond)"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1080\/10717544.2018.1492046","volume":"25","author":"Veloso D.F.M.C.","year":"2018","unstructured":"Veloso D.F.M.C.; Benedetti N.I.G.M.; \u00c1vila R.I.; Bastos T.S.A.; Silva T.C.; Silva M.R.R.; Batista A.C.; Valadares M.C.; Lima E.M.; Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity. Drug Deliv 2018,25(1),1585-1594","journal-title":"Drug Deliv"},{"key":"ref=62","first-page":"9","volume":"6","author":"Mishra B.","year":"2018","unstructured":"Mishra B.; Patel B.B.; Tiwari S.; Colloidal Nanocarriers\u202f: A review on formulation technology, types and applications toward targeted drug delivery colloidal Nanocarriers: A review on formulation technology, types and applications toward targeted drug delivery. nanomedicine nanotechnology. Biol Med (Aligarh) 2018,6,9-24","journal-title":"Biol Med (Aligarh)"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jsps.2011.04.001","volume":"19","author":"Mudshinge S.R.","year":"2011","unstructured":"Mudshinge S.R.; Deore A.B.; Patil S.; Bhalgat C.M.; Nanoparticles: Emerging carriers for drug delivery. Saudi Pharm J 2011,19(3),129-141","journal-title":"Saudi Pharm J"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/03639040802498864","volume":"35","author":"Barakat H.S.","year":"2009","unstructured":"Barakat H.S.; Darwish I.A.; El-Khordagui L.K.; Khalafallah N.M.; Development of naftifine hydrochloride alcohol-free niosome gel. Drug Dev Ind Pharm 2009,35(5),631-637","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1517\/17425247.2010.525230","volume":"7","author":"Kaur I.P.","year":"2010","unstructured":"Kaur I.P.; Kakkar S.; Topical delivery of antifungal agents. Expert Opin Drug Deliv 2010,7(11),1303-1327","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/03639045.2011.590731","volume":"38","author":"El-Hadidy G.N.","year":"2012","unstructured":"El-Hadidy G.N.; Ibrahim H.K.; Mohamed M.I.; El-Milligi M.F.; Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation. Drug Dev Ind Pharm 2012,38(1),64-72","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cis.2006.05.014","volume":"123-126","author":"Kogan A.","year":"2006","unstructured":"Kogan A.; Garti N.; Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 2006,123-126,369-385","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=68","first-page":"171","volume":"3","author":"Jose J.","year":"2015","unstructured":"Jose J.; Charyulu R.N.; Solubility enhancement of an antifungal agent by association with dendrimers. Indian J Res Pharm Biotecnol 2015,3,171-175","journal-title":"Indian J Res Pharm Biotecnol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/2230-973X.177833","volume":"6","author":"Jose J.","year":"2016","unstructured":"Jose J.; Charyulu R.N.; Prolonged drug delivery system of an antifungal drug by association with polyamidoamine dendrimers. Int J Pharm Investig 2016,6(2),123-127","journal-title":"Int J Pharm Investig"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fphar.2017.00261","volume":"8","author":"Choudhary S.","year":"2017","unstructured":"Choudhary S.; Gupta L.; Rani S.; Dave K.; Gupta U.; Impact of dendrimers on solubility of hydrophobic drug molecules. Front Pharmacol 2017,8,261","journal-title":"Front Pharmacol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jddst.2018.09.020","volume":"48","author":"Qurt M.S.","year":"2018","unstructured":"Qurt M.S.; Esent\u00fcrk \u0130.; Birteks\u00f6z Tan S.; Erdal M.S.; Araman A.; G\u00fcng\u00f6r S.; Voriconazole and sertaconazole loaded colloidal nano-carriers for enhanced skin deposition and improved topical fungal treatment. J Drug Deliv Sci Technol 2018,48,215-222","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.nano.2017.06.021","volume":"13","author":"Sosa L.","year":"2017","unstructured":"Sosa L.; Clares B.; Alvarado H.L.; Bozal N.; Domenech O.; Calpena A.C.; Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis. Nanomedicine 2017,13(7),2303-2312","journal-title":"Nanomedicine"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.chemphyslip.2012.01.006","volume":"165","author":"Gupta M.","year":"2012","unstructured":"Gupta M.; Vyas S.P.; Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids 2012,165(4),454-461","journal-title":"Chem Phys Lipids"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"142","DOI":"10.7324\/JAPS.2013.3924","volume":"3","author":"Tripathy S.","year":"2013","unstructured":"Tripathy S.; Das M.K.; Dendrimers and their applications as novel drug delivery carriers. J Appl Pharm Sci 2013,3,142-149","journal-title":"J Appl Pharm Sci"},{"key":"ref=75","first-page":"99","volume":"5","author":"Pawar V.","year":"2017","unstructured":"Pawar V.; Techniques implemented for solubility enhancement of ketoconazole: a review. Indian J Drugs 2017,5,99-103","journal-title":"Indian J Drugs"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"103","DOI":"10.18433\/J3K308","volume":"15","year":"2012","unstructured":"S, S.; S, A.; Krishnamoorthy, K.; Rajappan, M. Nanosponges: a novel class of drug delivery system--review. J Pharm Pharm Sci 2012,15(1),103-111","journal-title":"J Pharm Pharm Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3109\/10837451003739289","volume":"16","author":"Sharma R.","year":"2011","unstructured":"Sharma R.; Pathak K.; Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol 2011,16(4),367-376","journal-title":"Pharm Dev Technol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/499811","volume":"42","author":"Segal B.H.","year":"2006","unstructured":"Segal B.H.; Kwon-Chung J.; Walsh T.J.; Klein B.S.; Battiwalla M.; Almyroudis N.G.; Holland S.M.; Romani L.; Immunotherapy for fungal infections. Clin Infect Dis 2006,42(4),507-515","journal-title":"Clin Infect Dis"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20050749","volume":"202","author":"Torosantucci A.","year":"2005","unstructured":"Torosantucci A.; Bromuro C.; Chiani P.; De Bernardis F.; Berti F.; Galli C.; Norelli F.; Bellucci C.; Polonelli L.; Costantino P.; Rappuoli R.; Cassone A.; A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 2005,202(5),597-606","journal-title":"J Exp Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1084\/jem.20082818","volume":"206","author":"Robinson M.J.","year":"2009","unstructured":"Robinson M.J.; Osorio F.; Rosas M.; Freitas R.P.; Schweighoffer E.; Gross O.; Verbeek J.S.; Ruland J.; Tybulewicz V.; Brown G.D.; Moita L.F.; Taylor P.R.; Reis e Sousa C.; Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med 2009,206(9),2037-2051","journal-title":"J Exp Med"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1099\/13500872-140-7-1505","volume":"140","author":"Matthews R.C.","year":"1994","unstructured":"Matthews R.C.; Pathogenicity determinants of Candida albicans: potential targets for immunotherapy? Microbiology 1994,140(Pt 7),1505-1511","journal-title":"Microbiology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1086\/503428","volume":"42","author":"Pachl J.","year":"2006","unstructured":"Pachl J.; Svoboda P.; Jacobs F.; Vandewoude K.; van der Hoven B.; Spronk P.; Masterson G.; Malbrain M.; Aoun M.; Garbino J.; Takala J.; Drgona L.; Burnie J.; Matthews R.; Study C.A.; A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis Mycograb Invasive Candidiasis Study Group2006,42(10),1404-1413","journal-title":"Clin Infect Dis"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1086\/507547","volume":"43","author":"Herbrecht R.","year":"2006","unstructured":"Herbrecht R.; Fohrer C.; Nivoix Y.; Mycograb for the treatment of invasive candidiasis. Clin Infect Dis 2006,43(8),1083-1084","journal-title":"Clin Infect Dis"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1128\/IAI.68.3.1649-1654.2000","volume":"68","author":"Han Y.","year":"2000","unstructured":"Han Y.; Riesselman M.H.; Cutler J.E.; Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect Immun 2000,68(3),1649-1654","journal-title":"Infect Immun"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.4049\/jimmunol.168.6.2904","volume":"168","author":"Bacci A.","year":"2002","unstructured":"Bacci A.; Montagnoli C.; Perruccio K.; Bozza S.; Gaziano R.; Pitzurra L.; Velardi A.; d\u2019Ostiani C.F.; Cutler J.E.; Romani L.; Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol 2002,168(6),2904-2913","journal-title":"J Immunol"},{"key":"ref=86","first-page":"1063","volume":"34","author":"van de Veerdonk F.L.","year":"2010","unstructured":"van de Veerdonk F.L.; Netea M.G.; Joosten L.A.; van der Meer J.W.; Kullberg B.J.; Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy. Fed Eur Microbiol Soc 2010,34,1063-1075","journal-title":"Fed Eur Microbiol Soc"},{"key":"ref=87","first-page":"188","volume":"24","author":"Pupo Y.M.","year":"2011","unstructured":"Pupo Y.M.; Gomes G.M.; Santos E.B.; Chaves L.; Michel M.D.; Kozlowski V.A.; Gomes O.M.M.; Gomes J.C.; Susceptibility of Candida albicans to photodynamic therapy using methylene blue and toluidine blue as photosensitizing dyes. Acta Odontol Latinoam 2011,24(2),188-192","journal-title":"Acta Odontol Latinoam"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","volume":"90","author":"Dougherty T.J.","year":"1998","unstructured":"Dougherty T.J.; Gomer C.J.; Henderson B.W.; Jori G.; Kessel D.; Korbelik M.; Moan J.; Peng Q.; Photodynamic therapy. J Natl Cancer Inst 1998,90(12),889-905","journal-title":"J Natl Cancer Inst"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/pharmaceutics11010016","volume":"11","author":"Hsieh Y.H.","year":"2019","unstructured":"Hsieh Y.H.; Chuang W.C.; Yu K.H.; Jheng C.P.; Lee C.I.; Sequential photodynamic therapy with phthalocyanine encapsulated chitosan-tripolyphosphate nanoparticles and flucytosine treatment against Candida tropicalis. Pharmaceutics 2019,11(1),16","journal-title":"Pharmaceutics"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pdpdt.2019.06.005","volume":"27","author":"Afroozi B.","year":"2019","unstructured":"Afroozi B.; Zomorodian K.; Lavaee F.; Zare Shahrabadi Z.; Mardani M.; Comparison of the efficacy of indocyanine green-mediated photodynamic therapy and nystatin therapy in treatment of denture stomatitis. Photodiagn Photodyn Ther 2019,27,193-197","journal-title":"Photodiagn Photodyn Ther"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jiac.2018.08.011","volume":"24","author":"Fujimoto K.","year":"2018","unstructured":"Fujimoto K.; Takemoto K.; Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection. J Infect Chemother 2018,24(12),958-964","journal-title":"J Infect Chemother"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jphotobiol.2017.06.034","volume":"173","author":"Romio K.B.","year":"2017","unstructured":"Romio K.B.; Dos Santos K.F.; da Silva R.J.; Pedro M.F.C.; Kalck A.S.; da Silva Sousa M.; Possamai L.M.; Souto P.C.S.; Silva J.R.; de Souza N.C.; Incorporation of triclosan and acridine orange into liposomes for evaluating the susceptibility of Candida albicans. J Photochem Photobiol B 2017,173,514-521","journal-title":"J Photochem Photobiol B"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.colsurfb.2015.12.003","volume":"139","author":"Perez A.P.","year":"2016","unstructured":"Perez A.P.; Altube M.J.; Schilrreff P.; Apezteguia G.; Celes F.S.; Zacchino S.; de Oliveira C.I.; Romero E.L.; Morilla M.J.; Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro. Colloids Surf B Biointerfaces 2016,139,190-198","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"7445","DOI":"10.3390\/ijms14047445","volume":"14","author":"Chien H.F.","year":"2013","unstructured":"Chien H.F.; Chen C.P.; Chen Y.C.; Chang P.H.; Tsai T.; Chen C.T.; The use of Chitosan to enhance photodynamic inactivation against Candida albicans and its drug-resistant clinical isolates. Int J Mol Sci 2013,14(4),7445-7456","journal-title":"Int J Mol Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/ijms19020337","volume":"19","author":"Hsieh Y.H.","year":"2018","unstructured":"Hsieh Y.H.; Zhang J.H.; Chuang W.C.; Yu K.H.; Huang X.B.; Lee Y.C.; Lee C.I.; An in vitro study on the effect of combined treatment with photodynamic and chemical therapies on candida albicans. Int J Mol Sci 2018,19(2),337","journal-title":"Int J Mol Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mimet.2019.01.020","volume":"161","author":"Alhowyan A.A.","year":"2019","unstructured":"Alhowyan A.A.; Altamimi M.A.; Kalam M.A.; Khan A.A.; Badran M.; Binkhathlan Z.; Alkholief M.; Alshamsan A.; Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies. J Microbiol Methods 2019,161,87-95","journal-title":"J Microbiol Methods"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/jac\/dkn539","volume":"63","author":"Amaral A.C.","year":"2009","unstructured":"Amaral A.C.; Bocca A.L.; Ribeiro A.M.; Nunes J.; Peixoto D.L.G.; Simioni A.R.; Primo F.L.; Lacava Z.G.M.; Bentes R.; Titze-de-Almeida R.; Tedesco A.C.; Morais P.C.; Felipe M.S.; Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis. J Antimicrob Chemother 2009,63(3),526-533","journal-title":"J Antimicrob Chemother"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.archoralbio.2016.09.003","volume":"73","author":"Jothiprakasam V.","year":"2017","unstructured":"Jothiprakasam V.; Sambantham M.; Chinnathambi S.; Vijayaboopathi S.; Candida tropicalis biofilm inhibition by ZnO nanoparticles and EDTA. Arch Oral Biol 2017,73,21-24","journal-title":"Arch Oral Biol"},{"key":"ref=99","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/632698","volume":"2012","author":"Ing L.Y.","year":"2012","unstructured":"Ing L.Y.; Zin N.M.; Sarwar A.; Katas H.; Antifungal activity of chitosan nanoparticles and correlation with their physical properties. Int J Biomater 2012,2012","journal-title":"Int J Biomater"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijpharm.2007.10.009","volume":"352","author":"Peng H.S.","year":"2008","unstructured":"Peng H.S.; Liu X.J.; Lv G.X.; Sun B.; Kong Q.F.; Zhai D.X.; Wang Q.; Zhao W.; Wang G.Y.; Wang D.D.; Li H.L.; Jin L.H.; Kostulas N.; Voriconazole into PLGA nanoparticles: improving agglomeration and antifungal efficacy. Int J Pharm 2008,352(1-2),29-35","journal-title":"Int J Pharm"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/10717544.2017.1413444","volume":"25","author":"El-Housiny S.","year":"2018","unstructured":"El-Housiny S.; Shams Eldeen M.A.; El-Attar Y.A.; Salem H.A.; Attia D.; Bendas E.R.; El-Nabarawi M.A.; El-nabarawi M.A.; Atef M.; Eldeen S.; El-attar Y.A.; Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. Drug Deliv 2018,25(1),78-90","journal-title":"Drug Deliv"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.colsurfb.2015.07.032","volume":"139","author":"Butani D.","year":"2016","unstructured":"Butani D.; Yewale C.; Misra A.; Topical Amphotericin B solid lipid nanoparticles: Design and development. Colloids Surf B Biointerfaces 2016,139,17-24","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/IJN.S100625","volume":"11","author":"Aljaeid B.M.","year":"2016","unstructured":"Aljaeid B.M.; Hosny K.M.; Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity. Int J Nanomedicine 2016,11,441-447","journal-title":"Int J Nanomedicine"},{"key":"ref=104","first-page":"131","volume":"22","author":"Mukherjee S.","year":"2009","unstructured":"Mukherjee S.; Ray S.; Thakur R.S.; Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Pak J Pharm Sci 2009,22(2),131-138","journal-title":"Pak J Pharm Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1773-2247(10)50028-5","volume":"10","author":"Bianco M.A.","year":"2010","unstructured":"Bianco M.A.; Gallarate M.; Trotta M.B.L.; Amphotericin B loaded SLN prepared with the coacervation technique. J Drug Deliv Sci Technol 2010,10,187-191","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.3390\/molecules17044612","volume":"17","author":"Winnicka K.","year":"2012","unstructured":"Winnicka K.; Wroblewska M.; Wieczorek P.; Sacha P.T.; Tryniszewska E.; Hydrogel of ketoconazole and PAMAM dendrimers: formulation and antifungal activity. Molecules 2012,17(4),4612-4624","journal-title":"Molecules"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1248\/bpb.34.1129","volume":"34","author":"Winnicka K.","year":"2011","unstructured":"Winnicka K.; Sosnowska K.; Wieczorek P.; Sacha P.T.; Tryniszewska E.; Poly(amidoamine) dendrimers increase antifungal activity of clotrimazole. Biol Pharm Bull 2011,34(7),1129-1133","journal-title":"Biol Pharm Bull"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","volume":"33","author":"Bobo D.","year":"2016","unstructured":"Bobo D.; Robinson K.J.; Islam J.; Thurecht K.J.; Corrie S.R.; Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to Date. Pharm Res 2016,33(10),2373-2387","journal-title":"Pharm Res"},{"key":"ref=109","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1416","volume":"9","author":"Caster J.M.","year":"2017","unstructured":"Caster J.M.; Patel A.N.; Zhang T.; Wang A.; Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2017,9(1)","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=110","first-page":"512","volume":"37","author":"Ventola C.L.","year":"2012","unstructured":"Ventola C.L.; The nanomedicine revolution: part 1: emerging concepts. P 2012,37(9),512-525","journal-title":"P"},{"key":"ref=111","first-page":"742","volume":"42","author":"Ventola C.L.","year":"2017","unstructured":"Ventola C.L.; Progress in nanomedicine: Approved and investigational nanodrugs. P 2017,42(12),742-755","journal-title":"P"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3389\/fmicb.2017.00336","volume":"8","author":"Souza A.C.O.","year":"2017","unstructured":"Souza A.C.O.; Amaral A.C.; Antifungal therapy for systemic mycosis and the nanobiotechnology era: improving efficacy, biodistribution and toxicity. Front Microbiol 2017,8,336","journal-title":"Front Microbiol"},{"key":"ref=113","first-page":"1","volume":"3","author":"Bongomin F.","year":"2017","unstructured":"Bongomin F.; Gago S.; Oladele R.O.; Denning D.W.; Global and multi-national prevalence of fungal diseases-estimate precision. J fungi (Basel, Switzerland) 2017,3,1-29","journal-title":"J fungi (Basel, Switzerland)"},{"key":"ref=114","first-page":"21","volume":"2","author":"Gauniyal P.","year":"2014","unstructured":"Gauniyal P.; Vir U.; Teotia S.; Ethanolic C.; Antimicrobial activity and phytochemical analysis of ethanolic extracts of twelve medicinal plants against oral micro organisms. Int J Pharm Med Res 2014,2,21-27","journal-title":"Int J Pharm Med Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mycmed.2016.10.002","volume":"27","author":"Zida A.","year":"2017","unstructured":"Zida A.; Bamba S.; Yacouba A.; Ouedraogo-Traore R.; Guiguemd\u00e9 R.T.; Anti-Candida albicans natural products, sources of new antifungal drugs: A review. J Mycol Med 2017,27(1),1-19","journal-title":"J Mycol Med"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.indcrop.2018.10.064","volume":"127","author":"Baldim I.","year":"2019","unstructured":"Baldim I.; Tonani L.; Regina M.; Kress V.Z.; Oliveira W.P.; Industrial crops","journal-title":"Ind Crops Prod"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14786419.2018.1557175","volume":"22","author":"Donadu M.G.","year":"2019","unstructured":"Donadu M.G.; Usai D.; Marchetti M.; Usai M.; Mazzarello V.; Molicotti P.; Montesu M.A.; Delogu G.; Zanetti S.; Antifungal activity of oils macerates of North Sardinia plants against Candida species isolated from clinical patients with candidiasis. Nat Prod Res 2019,22,1-5","journal-title":"Nat Prod Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"16","DOI":"10.22354\/in.v23i1.750","volume":"23","author":"Mahboubi M.","year":"2018","unstructured":"Mahboubi M.; Attaran B.; Satureja khuzistanica jamzad essential oil and its anti-candidal activities against clinical isolates of candida albicans isolated from women with candidiasis. Infectio 2018,23,16","journal-title":"Infectio"},{"key":"ref=119","first-page":"171","volume":"20","author":"Ariamanesh H.","year":"2019","unstructured":"Ariamanesh H.; Tamizi N.; Yazdinezhad A.; Salah S.; Motamed N.; Amanloo S.; The effectiveness of nigella sativa alcoholic extract on the inhibition of candida albicans colonization and formation of plaque on acrylic denture plates: an in vitro study. J Dent (Shiraz) 2019,20(3),171-177","journal-title":"J Dent (Shiraz)"},{"key":"ref=120","first-page":"4","volume":"3","author":"Carvalho P.C. de L.","year":"2018","unstructured":"Carvalho P.C. de L.; de S\u00e1 N.P.; Lacerda I.C.A.; Pataro C.; Rosa L.H.; Alves R.S.; Lyon J.P.; Rosa C.A.; Johann S.; Anti-Candida activity of cinnamon inhibition of virulence factors of clinical strains of candida albicans by essential oil of cinnamomum zeylanicum. PSM Microbiol 2018,3,4-12","journal-title":"PSM Microbiol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jep.2018.04.042","volume":"224","author":"Napagoda M.","year":"2018","unstructured":"Napagoda M.; Gerstmeier J.; Butschek H.; Lorenz S.; Kanatiwela D.; Qader M.; Nagahawatte A.; De Soyza S.; Wijayaratne G.B.; Svato\u0161 A.; Jayasinghe L.; Koeberle A.; Werz O.; Lipophilic extracts of Leucas zeylanica, a multi-purpose medicinal plant in the tropics, inhibit key enzymes involved in inflammation and gout. J Ethnopharmacol 2018,224,474-481","journal-title":"J Ethnopharmacol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.bcab.2019.01.012","volume":"17","author":"Ngo-Mback M.N.L.","year":"2019","unstructured":"Ngo-Mback M.N.L.; MubarakAli, D.; Dongmo, P.M.J.; Boyom, F.F.; Thajuddin, N. Anti-candidal biofilm potential of solvent extracts of aeollanthus cucullathus (ryding) and its chemical analysis. Biocatal Agric Biotechnol 2019,17,595-604","journal-title":"Biocatal Agric Biotechnol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12906-018-2350-2","volume":"18","author":"da Costa Cordeiro B.M.P.","year":"2018","unstructured":"da Costa Cordeiro B.M.P.; de Lima Santos N.D.; Ferreira M.R.A.; de Ara\u00fajo L.C.C.; Junior A.R.C.; da Concei\u00e7\u00e3o Santos A.D.; de Oliveira A.P.; da Silva A.G.; da Silva Falc\u00e3o E.P.; Dos Santos Correia M.T.; da Silva Almeida J.R.G.; da Silva L.C.N.; Soares L.A.L.; Napole\u00e3o T.H.; da Silva M.V.; Paiva P.M.G.; Hexane extract from Spondias tuberosa (Anacardiaceae) leaves has antioxidant activity and is an anti-Candida agent by causing mitochondrial and lysosomal damages. BMC Complement Altern Med 2018,18(1),284","journal-title":"BMC Complement Altern Med"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jep.2004.11.016","volume":"97","author":"Duarte M.C.T.","year":"2005","unstructured":"Duarte M.C.T.; Figueira G.M.; Sartoratto A.; Rehder V.L.G.; Delarmelina C.; Anti-candida activity of brazilian medicinal plants. J Ethnopharmacol 2005,97(2),305-311","journal-title":"J Ethnopharmacol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12906-018-2425-0","volume":"19","author":"D\u2019Arrigo M.","year":"2019","unstructured":"D\u2019Arrigo M.; Bisignano C.; Irrera P.; Smeriglio A.; Zagami R.; Trombetta D.; Romeo O.; Mandalari G.; In vitro evaluation of the activity of an essential oil from Pistacia vera L. variety Bronte hull against Candida sp. BMC Complement Altern Med 2019,19(1),6","journal-title":"BMC Complement Altern Med"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1439-0507.2009.01690.x","volume":"53","author":"Tobudic S.","year":"2010","unstructured":"Tobudic S.; Lassnigg A.; Kratzer C.; Graninger W.; Presterl E.; Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases. Mycoses 2010,53(3),208-214","journal-title":"Mycoses"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.1007\/s00253-019-09960-3","volume":"103","author":"Lu Y.","year":"2019","unstructured":"Lu Y.; Zhou Z.; Mo L.; Guo Q.; Peng X.; Hu T.; Zhou X.; Ren B.; Xu X.; Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis. Appl Microbiol Biotechnol 2019,103(16),6701-6709","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3389\/fmicb.2019.01461","volume":"10","author":"Gong Y.","year":"2019","unstructured":"Gong Y.; Liu W.; Huang X.; Hao L.; Li Y.; Sun S.; Antifungal activity and potential mechanism of n-butylphthalide alone and in combination with fluconazole against candida albicans. Front Microbiol 2019,10,1461","journal-title":"Front Microbiol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13756-019-0521-7","volume":"8","author":"Yousfi H.","year":"2019","unstructured":"Yousfi H.; Ranque S.; Rolain J-M.; Bittar F.; In vitro polymyxin activity against clinical multidrug-resistant fungi. Antimicrob Resist Infect Control 2019,8,66","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/21505594.2015.1039885","volume":"6","author":"Cui J.","year":"2015","unstructured":"Cui J.; Ren B.; Tong Y.; Dai H.; Zhang L.; Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans. Virulence 2015,6(4),362-371","journal-title":"Virulence"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.3389\/fmicb.2019.01692","volume":"10","author":"Berzaghi R.","year":"2019","unstructured":"Berzaghi R.; Ag\u00f3cs A.; Curto M.A.; Guly\u00e1s-Fekete G.; Kocsis B.; Ribas J.C.; L\u00f3r\u00e1nd T.; Novel cell wall antifungals reveal a special synergistic activity in PBR1 mutants resistant to the glucan synthesis antifungals papulacandins and echinocandins. Front Microbiol 2019,10,1692","journal-title":"Front Microbiol"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/176289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T10:31:53Z","timestamp":1611657113000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/176289\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":131,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2019,12,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026619666191029145209","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}